【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I L.

智通财经05-22

【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I L.P.(以下简称“WuXi FundI”)与Longwood Special Situations Fund GP,LLC(以下简称“普通合伙人”)、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2437266390?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-05-22 19:11","share_image_url":"https://static.laohu8.com/6ca2dcdccfa2217fb20a0351f4efe814","id":"2437266390","market":"us","top_or_hot":-1,"title":"【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I L.","media":"智通财经","content":"<div>\n<p>【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I \n\nL.P.(以下简称“WuXi FundI”)与Longwood Special Situations Fund \n\nGP,LLC(以下简称“普通合伙人”)、...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n","source":"live_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7x24快讯</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7x24快讯\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-05-22 19:11 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/immediately.html?type=ganggu><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I \n\nL.P.(以下简称“WuXi FundI”)与Longwood Special Situations Fund \n\nGP,LLC(以下简称“普通合伙人”)、...</p>\n\n<a href=\"https://www.zhitongcaijing.com/immediately.html?type=ganggu\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0456842615.SGD","symbol_name":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","start_time":0,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","article_id":"2437266390","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2437266390","pubTimestamp":1716376300,"sourceInfo":{"source_id":"live_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Heal","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"603259":"药明康德","LU0456842615.SGD":"JPMorgan Funds - Emerging Markets Equity A (acc) SGD","BK4149":"建筑机械与重型卡车","LU0052750758.USD":"富兰克林中国基金A Acc","LU0320764599.SGD":"FTIF - Templeton China A Acc SGD","LU1046422090.SGD":"Fidelity Pacific A-SGD","BK0216":"研究试验","FUND":"Fund基金","GP":"GreenPower Motor Company Inc.","LU0708995583.HKD":"TEMPLETON CHINA \"A\" (HKD) ACC","LU1997245094.SGD":"安联神州A股基金AT Acc SGD","BK4582":"ESG ETF-MSCI","LU1997245177.USD":"安联神洲A股基金","BK1141":"生命科学工具和服务","BK1576":"医药外包概念","LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","LU2242644610.SGD":"Fidelity China Innovation A-ACC-SGD","02359":"药明康德","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","BK4139":"生物科技","WOOD":"iShares S&P Global Timber &Fores","BK1583":"高瓴概念"},"translate_title":"[WuXi AppTec (02359. HK) plans to spend US $5 million to subscribe for private equity fund shares] Zhitong Finance APP News, WuXi AppTec (02359. HK) announced that on May 22, 2024, the company's wholly-owned subsidiary WuXi Pharma Tech Healthcare Fund I L.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"603259":1,"WOOD":1,"VIRI":1,"GP":1,"FUND":1,"02359":1},"content_text":"【药明康德(02359.HK)拟斥资500万美元认购私募基金份额】智通财经APP讯，药明康德(02359.HK)发布公告，2024年5月22日，公司全资子企业WuXi Pharma Tech Healthcare Fund I \n\nL.P.(以下简称“WuXi FundI”)与Longwood Special Situations Fund \n\nGP,LLC(以下简称“普通合伙人”)、Longwood Management,LLC(以下简称“管理公司”)签署Amendedand Restated \n\nLimited Partnership Agreement(以下简称“合伙协议”)，以及签署Investor \n\nQuestionnaire(“投资人问卷”)，约定由WuXi FundI认缴LONG WOOD SPECIAL SITUATIONS \n\nFUND,L.P.(“投资基金”)500万美元的投资基金份额，约占已募集投资基金份额的4.52%(Wu Xi \n\nFundI所持投资基金份额比例将随投资基金后续募集金额增加而进一步稀释)。截至本公告日，WuXi FundI尚未支付投资款，后续WuXi \n\nFundI将以自有资金根据合伙协议的要求履行投资款的支付义务。","kind":null,"is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2437266390"}